RSS Feeds
Rochalimaea Infections
- Jordan W. Tappero, MD; and
- Jane E. Koehler, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
We read with interest the concise editorial by Drs. Tompkins and Steigbigel [1] accompanying our article [2] describing the only immunocompetent patients reported in the literature with angiomatosis in the absence of human immunodeficiency virus infection or drug-induced immune suppression. Stating that bacillary angiomatosis in immunocompetent adults had been previously reported, the authors incorrectly cited three articles describing patients who had fever and bacteremia caused by Rochalimaea species but did not have the vascular lesions of either bacillary angiomatosis or parenchymal bacillary peliosis [3-5]. The error is frequently made and could lead to further confusion. The distinction is important to clinicians because it assists in defining the spectrum of disease for Rochalimaea infections, which includes fever and bacteremia, endocarditis, and cat scratch disease as well as bacillary angiomatosis. In addition, it is important to epidemiologists and molecular biologists attempting to determine why only a subset of Rochalimaea infections is associated with vascular proliferative lesions.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
- Copyright 2004 by the American College of Physicians
